The two pharmaceutical companies closest to gaining U.S. clearance for a Covid-19 vaccine won’t attend a planned White House summit intended to build confidence in the shots.
Pfizer Inc. said in a statement that it had informed the White House that it wouldn’t attend the Tuesday event. Moderna Inc. executives also won’t be present, according to a person familiar with the matter.
Both companies are seeking emergency-use authorization for their experimental vaccines. A group of outside advisers to the U.S. Food and Drug Administration is scheduled to consider the case for clearing Pfizer’s shot, which it is developing with German drugmaker BioNTech SE, this Thursday. An advisory panel is set to scrutinize Moderna’s shot at a meeting on Dec. 17.
Soon after each of those meetings, the FDA could grant authorization for the shots, setting off what is expected to be one of the largest mass immunization efforts in history.
The Tuesday meeting hosted by President Donald Trump is designed to boost confidence in the shots at a time when some groups have voiced reluctance to take them. The summit is likely to focus on distribution, with Trump planning to sign an order directing his Department of Health and Human Services to prioritize getting them to people in the U.S. before helping other countries.
FDA officials are expected to appear at the meeting, and it would be inappropriate for the drugmaker to attend while its application for authorization is pending with the agency, the person familiar with Moderna’s plans said.
Article From & Read More ( Moderna, Pfizer Won't Attend White House Summit on Vaccines - Newsmax )https://ift.tt/3lWgreP
Business
Bagikan Berita Ini
0 Response to "Moderna, Pfizer Won't Attend White House Summit on Vaccines - Newsmax"
Post a Comment